These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27481908)

  • 21. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking.
    Panoulas VF; Stavropoulos-Kalinoglou A; Metsios GS; Smith JP; Milionis HJ; Douglas KM; Nightingale P; Kitas GD
    Atherosclerosis; 2009 May; 204(1):178-83. PubMed ID: 18848327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study.
    Monk HL; Muller S; Mallen CD; Hider SL
    BMC Fam Pract; 2013 Oct; 14():150. PubMed ID: 24106825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population.
    Bili A; Schroeder LL; Ledwich LJ; Kirchner HL; Newman ED; Wasko MC
    Rheumatol Int; 2011 Sep; 31(9):1159-65. PubMed ID: 20349066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year incidence of common comorbidities, such as hypertension, dyslipidemia, diabetes mellitus, cardiovascular disease, cerebrovascular disease and cancer, in older Japanese patients with rheumatoid arthritis.
    Mochizuki T; Ikari K; Yano K; Okazaki K
    Geriatr Gerontol Int; 2019 Jul; 19(7):577-581. PubMed ID: 30950139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations.
    Primdahl J; Clausen J; Hørslev-Petersen K
    Ann Rheum Dis; 2013 Nov; 72(11):1771-6. PubMed ID: 23852694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
    Giollo A; Bissell LA; Buch MH
    Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis.
    Brady SR; de Courten B; Reid CM; Cicuttini FM; de Courten MP; Liew D
    J Rheumatol; 2009 Jan; 36(1):34-40. PubMed ID: 19012364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
    Stavropoulos-Kalinoglou A; Metsios GS; Panoulas VF; Douglas KM; Nevill AM; Jamurtas AZ; Kita M; Koutedakis Y; Kitas GD
    Ann Rheum Dis; 2009 Feb; 68(2):242-5. PubMed ID: 18677010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory arthritis as a novel risk factor for cardiovascular disease.
    John H; Kitas G
    Eur J Intern Med; 2012 Oct; 23(7):575-9. PubMed ID: 22841864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
    Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
    Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record.
    Adhikesavan LG; Newman ED; Diehl MP; Wood GC; Bili A
    Arthritis Rheum; 2008 Dec; 59(12):1705-12. PubMed ID: 19035412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
    Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular Disease Prevention in Rheumatoid Arthritis: Compliance with Diabetes Screening Guidelines.
    Schmidt TJ; Aviña-Zubieta JA; Sayre EC; Abrahamowicz M; Esdaile JM; Lacaille D
    J Rheumatol; 2018 Oct; 45(10):1367-1374. PubMed ID: 30008457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    Crowson CS; Rollefstad S; Kitas GD; van Riel PL; Gabriel SE; Semb AG;
    PLoS One; 2017; 12(3):e0174656. PubMed ID: 28334012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis.
    Bartels CM; Kind AJ; Everett C; Mell M; McBride P; Smith M
    Arthritis Rheum; 2011 May; 63(5):1221-30. PubMed ID: 21305507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
    Arts EE; Fransen J; den Broeder AA; Popa CD; van Riel PL
    Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk factors in women with and without rheumatoid arthritis.
    Solomon DH; Curhan GC; Rimm EB; Cannuscio CC; Karlson EW
    Arthritis Rheum; 2004 Nov; 50(11):3444-9. PubMed ID: 15529391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.